Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Net Margin (2010 - 2026)

Updated

Vistagen Therapeutics (VTGN) recorded Net Margin of -7782.61% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 256.64 percentage points from -7525.97% a year earlier and down 6899.82 percentage points from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Net Margin (2010 - 2026) Analysis & Trends

On a TTM basis, Vistagen Therapeutics' Net Margin came in at -2474.52% as of Sep 30, 2026, up 6157.38 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5491.33%, up 5088.50 percentage points from FY2025.

  • Annual Net Margin has a five-year change of -1607.00 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Net Margin came in at -10579.84% in FY2025 (-7820.25 pp), -2759.59% in FY2024 (+23340.72 pp), -26100.31% in FY2023 (-21708.29 pp) and -4392.02% in FY2022 (-507.69 pp).
  • The fiscal Q2 2027 figure is the lowest quarterly Net Margin since fiscal Q1 2025.
  • On a year-over-year basis, Net Margin rose in two of the last six quarters, with an average year-over-year change of +1083.70 percentage points.
  • Peak year-over-year performance for Net Margin in the last five years was a gain of 35842.58 percentage points in fiscal Q4 2023, against a drop of 36101.96 percentage points in fiscal Q4 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -882.79% (Q1 2027), -3499.78% (Q4 2026) and -6237.29% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -973.44%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 26.44%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 0.83%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 24.24%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 28.01%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 37.28%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 29.27%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -7,782.61%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -7,782.61%
Jun 30, 2026 -882.79%
Mar 31, 2026 -3,499.78%
Dec 31, 2025 -6,237.29%
Sep 30, 2025 -7,525.97%
Jun 30, 2025 -6,186.48%
Dec 31, 2024 -6,020.94%
Sep 30, 2024 -7,082.51%
Jun 30, 2024 -12,777.38%
Mar 31, 2024 -5,805.49%
Dec 31, 2023 -1,545.01%
Sep 30, 2023 -2,196.00%
Jun 30, 2023 -3,451.50%
Mar 31, 2023 -6,947.16%
Dec 31, 2022 -5,422.89%
Sep 30, 2022 -1,957.81%
Jun 30, 2022 -6,377.39%
Mar 31, 2022 -42,789.74%
Dec 31, 2021 -3,000.56%
Sep 30, 2021 -3,678.77%
API Access

Vistagen Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY